opioids
FinancePurdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers
By Geoff Mulvihill and The Associated PressMarch 19, 2025
By The Associated Press and Jesse BedaynFebruary 4, 2025
HealthPurdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll
By Geoff Mulvihill and The Associated PressJanuary 24, 2025
HealthOhio Supreme Court says counties can’t sue pharmacy chains in decision that could overturn a $650 million opioid judgment
By Julie Carr Smyth and The Associated PressDecember 11, 2024
HealthArkansas is suing pharmacy benefit managers Express Scripts and Optum, accusing them of fueling the state’s opioid crisis
By Andrew DeMillo and The Associated PressJune 25, 2024
By Adam Beam and The Associated PressApril 29, 2024
HealthOxyContin marketer and opioid maker announce $500m in settlements to avoid trials on their responsibility for crisis
By Geoff Mulvihill and The Associated PressFebruary 2, 2024
HealthEBay will pay $59m settlement over pill presses sold on the site—the kind used to make counterfeit pills laced with fentanyl
By Lindsay Whitehurst and The Associated PressFebruary 1, 2024
FinanceOxyContin-maker Purdue Pharma heads to Supreme Court in case over whether $6bn payoff can shield Sackler owners from future lawsuits
By Mark Sherman and The Associated PressDecember 4, 2023
HealthWhite patients are more likely than Black patients to be prescribed opioids for pain in US emergency departments. Here’s why it matters
By Trevor Thompson, Sofia Stathi and The ConversationOctober 29, 2023
By Tom Murphy, Elaine Kurtenbach and The Associated PressOctober 17, 2023
HealthThe opioid crisis is so bad that prosecutors are starting to charge drug addict parents with their kids’ Fentanyl overdoses
By Olga R. Rodriguez and The Associated PressSeptember 8, 2023
LeadershipBiden’s DOJ doesn’t think the Sackler family should get released from opioid liability and the Supreme Court agrees—for now
By Mark Sherman and The Associated PressAugust 10, 2023
Most Popular
